 |
|
|
| |
Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) Versus Dolutegravir (DTG)-Based 3-Drug Regimens in Adults With HIV Who Have Suboptimal Antiretroviral Adherence
|
| |
| |
ID Week 2023 Oct 11
risten Andreatta,1 Paul E. Sax,2 David Wohl,3 Michelle L. D'Antoni,1 Hailin Huang,1 Jason Hindman,1 Christian Callebaut,1 Hal Martin1
1Gilead Sciences, Inc., Foster City, CA, U.S.A.; 2Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, U.S.A.; 3Division of Infectious Diseases, University of North Carolina, Chapel Hill, NC, U.S.A
|
| |
|
|
|
|
|
